Key facts
- This page summarizes Jonathan Violin's Form 4/A - Amendment filing for Viridian Therapeutics, Inc.\DE (VRDN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Feb 2023, 17:35.
Jonathan Violin - 02 Feb 2023 Form 4/A - Amendment Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- VRDN
- Reported as of
- 02 Feb 2023
- Net transaction value
- -$1,832,500
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 07 Feb 2023, 17:35:01 UTC
- Original report date
- 07 Feb 2023
- Prior SEC filing
- 21 Jun 2022
- Next SEC filing
- 06 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lara Meisner, Attorney-in-Fact for Jonathan Violin
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Violin filed Form 4/A - Amendment for Viridian Therapeutics, Inc.\DE (VRDN) on 07 Feb 2023.
Change
- Previous filing in this sequence was filed on 21 Jun 2022.
- Current net transaction value: -$1,832,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRDN
transaction
Common Stock
Options Exercise
- Transaction value
- $7,500
- Shares
- +50,000
- Change %
- +10%
- Price
- $0.1500*
- Shares after
- 530,905
- Date
- 02 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
VRDN
transaction
Common Stock
Sale
- Transaction value
- $1,840,000
- Shares
- -50,000
- Change %
- -9.4%
- Price
- $36.80
- Shares after
- 480,905
- Date
- 02 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VRDN
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -50,000
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 239,205
- Date
- 02 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.1500
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Jonathan Violin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Due to a broker error, the Form 4 filed by the Reporting Person on February 3, 2023 incorrectly reported the source of shares sold on February 2, 2023 pursuant to the Reporting Person's Rule 10b5-1 trading plan. This amendment reflects the exercise of stock options for 50,000 shares of common stock, which were the source of the shares sold.
Footnote F2
This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $36.1523 to $37.3689. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
The option vested 25% on September 23, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.